Residual cardiomyocytes and scintigraphic findings in advanced coronary artery disease -Correlation with technetium-99m-tetrofosmin and thallium-201 single photon emission computed tomography-

Japanese Circulation Journal

Volumn 63, Issue 1, 1999, Pages 64-67

  Fujino, Susumu ^a,c   Matsunari, Ichiro ^b   Saga, Takashi ^a   Okazaki, Hideaki ^a   Haraki, Tatsuo ^a   Aoyama, Takahiko ^a   Hirai, Jun Ichi ^a   Doishita, Kenji ^a   Takekoshi, Noboru ^c  

^a Fukui Prefectural Hospital   (Japan)

^b Medical and Pharmacological Research Center Foundation   (Japan)

^c KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

Myocardial viability; Single photon emission computed tomographic (SPECT) imaging; Technetium 99m tetrofosmin; Thallium 201

Indexed keywords

TETROFOSMIN TC 99M; THALLIUM 201;

AGED; ARTICLE; AUTOPSY; CASE REPORT; COLLIMATOR; CORONARY ARTERY DISEASE; HEART FAILURE; HEART MUSCLE CELL; HEART SCINTISCANNING; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AGED; CELL SURVIVAL; CORONARY DISEASE; HEART; HUMANS; MALE; MYOCARDIUM; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; THALLIUM RADIOISOTOPES; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0032902845     PISSN: 00471828     EISSN: None     Source Type: Journal    
DOI: 10.1253/jcj.63.64     Document Type: Article

References (12)

1. Matsunari I, Fujino S, Taki J, Senm J, Aoyama T, Wakasugi T, et al: Myocardial viability assessment with technetium-99m-tetrofosmin and thallium-201 reinjection in coronary artery disease. J Nucl Med 1995; 36: 1961-1967
2. Matsunari I, Fujino S, Taki J, Senma S, Aoyama T, Wakasugi T, et al: Quantitative rest technetium-99m tetrofosmin imaging in predicting functional recovery after revascularization: comparison with restredistribution thallium-201. J Am Coll Cardiol 1997; 29: 1226-1233
3. Matsunari I, Tanishima Y, Taki J, Ono K, Nishide H, Fujino S, et al: Early and delayed technetium-99m-tetrofosmin myocardial SPECT compared in normal volunteers. J Nucl Med 1996; 37: 1622-1626
4. Kitamura M, Shimizu M, Kita Y, Yoshio H, Ino H, Misawa K, et al: Quantitative evaluation of the rate of myocardial interstitial fibrosis using a personal computer. Jpn Circ J 1997; 61: 781-786
5. Takahashi N, Reinhardt CP, Marcel R, Leppo JA: Myocardial uptake of 99mTc-tetrofosmin, sestamibi, and 201T1 in a model of acutecoronary reperfusion. Circulation 1996; 94: 2605-2613
6. Medrano R, Lowry RW, Young JB, Weilbaecher DG, Michael LH, Afridi I. et al: Assessment of myocardial viability with 99mTc Sestamibi in patients undergoing cardiac transplantation: A scintigraphic/histological study. Circulation 1996; 94: 1010-1017
7. Maria RD, Ruffini L, Testa R, Parolini M, Mangiavacchi M, Vitali E, et al: Correlation between extent of myocardial dysfunction and markers of irreversible damage in failing hearts. J Nucl Cardiol 1997; 4: 441-450
8. Zimmermann R, Mall G, Rauch B, Zimmer G, Gabel M, Zehelein J, et al: Residual 201T1 activity in irreversible defects as a marker of myocardial viability: Clinicopathological study. Circulation 1995: 91: 1016-1021
9. Macs AF, Borgers M, Flameng W, Nuyts JL, Werf FVD, Ausma JJ, et al: Assessment of myocardial viability in chronic coronary artery disease using technetium-99m sestamibi SPECT: correlation with histologic and positron emission tomographic studies and functional follow-up. J Am Coll Cardiol 1997; 29: 62-68
10. Dakik HA, Howell JF, Lawrie GM, Espada R, Weilbaecher DG, He ZX, et al: Assessment of myocardial viability with 99mTc-sestamibi tomography before coronary bypass graft surgery: Correlation with histopathology and postoperative improvement in cardiac function. Circulation 1997; 96: 2892-2898
11. Maes A, Flameng W, Nuyts J, Borgers M, Shivalkar B, Ausma J, et al: Histological alterations in chronically hypoperfused myocardium: Correlation with PET findings. Circulation 1994; 90: 735-745
12. Depré C, Vanoverschelde JLJ, Gerber B, Borgers M, Mekin JA, Dion R: Correlation of functional recovery with myocardial blood flow, glucose uptake, and morphometric features in patients with chronic left ventricular ischemic dysfunction undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 1997; 113: 371-378